Search research articles
Contact Us
Filters
Showing results (561-570 of 832) with videos related to
Page
of 84
Sort By:
The Journal of Clinical Endocrinology and Metabolism
|
November 1, 1990
The pharmacodynamic inhibition of estrogen synthesis by fadrozole, an aromatase inhibitor, and its pharmacokinetic disposition
G M Kochak, S Mangat, M T Mulagha, et al.
Journal of Surgical Oncology
|
September 1, 1982
Estrogen receptor status in inflammatory breast carcinoma
H A Harvey, A Lipton, B V Lawrence, et al.
Nature Neuroscience
|
December 22, 1999
Molecular basis of NMDA receptor-coupled ion channel modulation by S-nitrosylation
Y B Choi, L Tenneti, D A Le, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 13, 2006
Activation of the Keap1/Nrf2 pathway for neuroprotection by electrophilic [correction of electrophillic] phase II inducers
T Satoh, S-i Okamoto, J Cui, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
April 1, 1975
Effects of thyrotropin-releasing hormone (TRH) on the actions of pentobarbital and other centrally acting drugs
G R Breese, J M Cott, B R Cooper, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 17, 2001
Safety and efficacy of bisphosphonates beyond 24 months in cancer patients
S M Ali, F J Esteva, G Hortobagyi, et al.
Experientia
|
August 15, 1973
A comparison of the pharmacological activity of delta 9-tetrahydrocannabinol and its monohydroxylated metabolites in man
M Perez-Reyes, M C Timmons, M A Lipton, et al.
Investigative Ophthalmology & Visual Science
|
July 25, 2017
Molecular Pathway to Protection From Age-Dependent Photoreceptor Degeneration in Mef2 Deficiency
Saumya Nagar, Dorit Trudler, Scott R McKercher, et al.
Archives of General Psychiatry
|
July 1, 1973
THR (lopremone): psychobiological responses of normal women. I. Subjective experiences
I C Wilson, A J Prange, P P Lara, et al.
Psychosomatics
|
September 1, 1970
Use of a thyroid hormone to accelerate the action of imipramine
A J Prange, I C Wilson, M A Lipton, et al.
Page
of 84
Search research articles
Search
Showing results (561-570 of 832) with videos related to
Sort By:
Page
of 84
The Journal of Clinical Endocrinology and Metabolism
|
November 1, 1990
The pharmacodynamic inhibition of estrogen synthesis by fadrozole, an aromatase inhibitor, and its pharmacokinetic disposition
G M Kochak, S Mangat, M T Mulagha, et al.
Journal of Surgical Oncology
|
September 1, 1982
Estrogen receptor status in inflammatory breast carcinoma
H A Harvey, A Lipton, B V Lawrence, et al.
Nature Neuroscience
|
December 22, 1999
Molecular basis of NMDA receptor-coupled ion channel modulation by S-nitrosylation
Y B Choi, L Tenneti, D A Le, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 13, 2006
Activation of the Keap1/Nrf2 pathway for neuroprotection by electrophilic [correction of electrophillic] phase II inducers
T Satoh, S-i Okamoto, J Cui, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
April 1, 1975
Effects of thyrotropin-releasing hormone (TRH) on the actions of pentobarbital and other centrally acting drugs
G R Breese, J M Cott, B R Cooper, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 17, 2001
Safety and efficacy of bisphosphonates beyond 24 months in cancer patients
S M Ali, F J Esteva, G Hortobagyi, et al.
Experientia
|
August 15, 1973
A comparison of the pharmacological activity of delta 9-tetrahydrocannabinol and its monohydroxylated metabolites in man
M Perez-Reyes, M C Timmons, M A Lipton, et al.
Investigative Ophthalmology & Visual Science
|
July 25, 2017
Molecular Pathway to Protection From Age-Dependent Photoreceptor Degeneration in Mef2 Deficiency
Saumya Nagar, Dorit Trudler, Scott R McKercher, et al.
Archives of General Psychiatry
|
July 1, 1973
THR (lopremone): psychobiological responses of normal women. I. Subjective experiences
I C Wilson, A J Prange, P P Lara, et al.
Psychosomatics
|
September 1, 1970
Use of a thyroid hormone to accelerate the action of imipramine
A J Prange, I C Wilson, M A Lipton, et al.
Page
of 84